A recent study indicates that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle plans.
Published data in a major health publication demonstrates that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing such drugs must be aware of the potential of fast rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting weight in about a year and a half.
Analyzing Approaches
The analysis, which reviewed 37 of studies involving thousands of participants, contrasted the effects of these new drugs with older methods.
Researchers point out that individuals who shed pounds through lifestyle changes alone generally see a slower creep back—around 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Doctors suggest the way of the drugs is key to understanding the heightened weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Long-term administration of GLP-1 concentrations several times higher than normal may cause the body to produce less of its own natural hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication results in hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Disease?
The NHS advise the jabs for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.
A number of clinicians argue that, considering the high risk of weight regain, the treatment should be considered life-long.
This view is echoed by drug manufacturers, who say that the findings "emphasize the long-term character of excess weight," comparing it to managing conditions like high blood pressure.
Patient Experiences
People who have discontinued the medication report a sudden return of hunger.
"I experienced a switch flipping and you become extremely hungry," described one woman.
This difficulty is compounded if users have not established sustainable lifestyle or habit modifications during treatment.
Significant Use
Survey data indicate that a significant number of people in the UK have tried these injections in the last 12 months, with demand remaining high.
- Adoption is more common among women compared to men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while the jabs are effective agents for weight loss, they are not a permanent solution and lasting health benefits relies on combined behavioural support.
